Cargando…

Genome-Wide Mapping of Bivalent Histone Modifications in Hepatic Stem/Progenitor Cells

The “bivalent domain,” a distinctive histone modification signature, is characterized by repressive trimethylation of histone H3 at lysine 27 (H3K27me3) and active trimethylation of histone H3 at lysine 4 (H3K4me3) marks. Maintenance and dynamic resolution of these histone marks play important roles...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanayama, Kengo, Chiba, Tetsuhiro, Oshima, Motohiko, Kanzaki, Hiroaki, Koide, Shuhei, Saraya, Atsunori, Miyagi, Satoru, Mimura, Naoya, Kusakabe, Yuko, Saito, Tomoko, Ogasawara, Sadahisa, Suzuki, Eiichiro, Ooka, Yoshihiko, Maruyama, Hitoshi, Iwama, Atsushi, Kato, Naoya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466853/ https://www.ncbi.nlm.nih.gov/pubmed/31065285 http://dx.doi.org/10.1155/2019/9789240

Ejemplares similares

Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma
por: Yokoyama, Masayuki, et al.
Publicado: (2017)

Disulfiram Eradicates Tumor-Initiating Hepatocellular Carcinoma Cells in ROS-p38 MAPK Pathway-Dependent and -Independent Manners
por: Chiba, Tetsuhiro, et al.
Publicado: (2014)

Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance
por: Maruyama, Hitoshi, et al.
Publicado: (2018)

Akt inhibition synergizes with polycomb repressive complex 2 inhibition in the treatment of multiple myeloma
por: Rizk, Mohamed, et al.
Publicado: (2019)

Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
por: Saito, Tomoko, et al.
Publicado: (2013)

Long-term administration of Tolvaptan to patients with decompensated cirrhosis
por: Kanayama, Kengo, et al.
Publicado: (2020)

Serum fibroblast growth factor 19 serves as a potential novel biomarker for hepatocellular carcinoma
por: Maeda, Takahiro, et al.
Publicado: (2019)

EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
por: Kusakabe, Yuko, et al.
Publicado: (2021)

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)

Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma
por: Suzuki, Eiichiro, et al.
Publicado: (2014)

Switching to systemic therapy after locoregional treatment failure: Definition and best timing
por: Ogasawara, Sadahisa, et al.
Publicado: (2020)

Successful Interventional Treatment for Arterioportal Fistula Caused by Radiofrequency Ablation for Hepatocellular Carcinoma
por: Kanogawa, Naoya, et al.
Publicado: (2014)

Incidence and hemodynamic feature of risky esophageal varices with lower hepatic venous pressure gradient
por: Maruyama, Hitoshi, et al.
Publicado: (2019)

The TIF1β-HP1 System Maintains Transcriptional Integrity of Hematopoietic Stem Cells
por: Miyagi, Satoru, et al.
Publicado: (2014)

A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Ogasawara, Sadahisa, et al.
Publicado: (2015)

Impact of Radiofrequency Ablation-Induced Glisson’s Capsule-Associated Complications in Patients with Hepatocellular Carcinoma
por: Wakamatsu, Toru, et al.
Publicado: (2017)

Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma
por: Ishikawa, Kentaro, et al.
Publicado: (2018)

Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
por: Ooka, Yoshihiko, et al.
Publicado: (2014)

Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016)

Fatal Diaphragmatic Hernia following Radiofrequency Ablation for Hepatocellular Carcinoma: A Case Report and Literature Review
por: Saito, Tomoko, et al.
Publicado: (2015)

Effect of Previous Interferon-based Therapy on Recurrence after Curative Treatment of Hepatitis C Virus-related Hepatocellular Carcinoma
por: Saito, Tomoko, et al.
Publicado: (2014)

Compensating effect of minor portal hypertension on the muscle mass loss-related poor prognosis in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2017)

Successful Treatment of Hepatocellular Carcinoma Complicated by Fanconi Anemia
por: Takahashi, Koji, et al.
Publicado: (2017)

Henoch-Schönlein Purpura Complicated by Hepatocellular Carcinoma
por: Akizue, Naoki, et al.
Publicado: (2017)

Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma
por: Ogasawara, Sadahisa, et al.
Publicado: (2016)

Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
por: Ao, Junjie, et al.
Publicado: (2021)

Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

Successful retreatment with grazoprevir and elbasvir for patients infected with hepatitis C virus genotype 1b, who discontinued prior treatment with NS5A inhibitor-including regimens due to adverse events
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Intracranial Metastasis in a Patient with Hepatocellular Carcinoma and Gastric Cancer
por: Tawada, Akinobu, et al.
Publicado: (2014)

The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells
por: Nagai, Yurie, et al.
Publicado: (2021)

The efficacy of contrast-enhanced computed tomography on the management of gastroesophageal varices in patients with hepatocellular carcinoma
por: Kondo, Takayuki, et al.
Publicado: (2022)

Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Real-World Experiences with the Combination Treatment of Ledipasvir plus Sofosbuvir for 12 Weeks in HCV Genotype 1-Infected Japanese Patients: Achievement of a Sustained Virological Response in Previous Users of Peginterferon plus Ribavirin with HCV NS3/4A Inhibitors
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Successful Resection of Intracranial Metastasis of Hepatocellular Carcinoma
por: Okimoto, Kenichiro, et al.
Publicado: (2013)

Bmi1 Confers Resistance to Oxidative Stress on Hematopoietic Stem Cells
por: Nakamura, Shunsuke, et al.
Publicado: (2012)

Correction: UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease
por: Rizq, Ola, et al.
Publicado: (2023)

UTX inactivation in germinal center B cells promotes the development of multiple myeloma with extramedullary disease
por: Rizq, Ola, et al.
Publicado: (2023)

Simultaneous Resection of Disseminated Hepatocellular Carcinoma and Colon Cancer
por: Haga, Yuki, et al.
Publicado: (2013)

Ezh1 Targets Bivalent Genes to Maintain Self-Renewing Stem Cells in Ezh2-Insufficient Myelodysplastic Syndrome
por: Aoyama, Kazumasa, et al.
Publicado: (2018)

How we use hepatic arterial infusion chemotherapy in the new era of systemic therapy?
por: Ogasawara, Sadahisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tnr3ce8937cdfttusb4v832f7e